Literature DB >> 33832857

[Neonatal-onset Niemann-Pick type C disease with COVID-19 infection].

Olga Bueno-Lozano1, Sofía Valle-Guillén1, Gerardo Rodríguez2, Laura López de Frutos3, Purificación Ventura-Faci2.   

Abstract

Entities:  

Year:  2021        PMID： 33832857      PMCID： PMC7931683          DOI： 10.1016/j.anpedi.2021.02.014

Source DB:  PubMed          Journal:  An Pediatr (Engl Ed)        ISSN： 2341-2879


× No keyword cloud information.
  6 in total

1.  Niemann-Pick disease type C in the newborn period: a single-center experience.

Authors:  Ersin Gumus; Goknur Haliloglu; Asuman Nur Karhan; Hulya Demir; Figen Gurakan; Meral Topcu; Aysel Yuce
Journal:  Eur J Pediatr       Date:  2017-09-27       Impact factor: 3.183

2.  Pulmonary involvement in Niemann-Pick C type 1.

Authors:  Orna Staretz-Chacham; M Aviram; I Morag; A Goldbart; E Hershkovitz
Journal:  Eur J Pediatr       Date:  2018-07-31       Impact factor: 3.183

3.  Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China.

Authors:  Min Wei; Jingping Yuan; Yu Liu; Tao Fu; Xue Yu; Zhi-Jiang Zhang
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

4.  The natural history of Niemann-Pick disease type C in the UK.

Authors:  J Imrie; S Dasgupta; G T N Besley; C Harris; L Heptinstall; S Knight; M T Vanier; A H Fensom; C Ward; E Jacklin; C Whitehouse; J E Wraith
Journal:  J Inherit Metab Dis       Date:  2006-12-11       Impact factor: 4.982

Review 5.  Diagnostic tests for Niemann-Pick disease type C (NP-C): A critical review.

Authors:  Marie T Vanier; Paul Gissen; Peter Bauer; Maria J Coll; Alberto Burlina; Christian J Hendriksz; Philippe Latour; Cyril Goizet; Richard W D Welford; Thorsten Marquardt; Stefan A Kolb
Journal:  Mol Genet Metab       Date:  2016-06-07       Impact factor: 4.797

6.  The lysosome: A potential juncture between SARS-CoV-2 infectivity and Niemann-Pick disease type C, with therapeutic implications.

Authors:  Rami A Ballout; Dmitri Sviridov; Michael I Bukrinsky; Alan T Remaley
Journal:  FASEB J       Date:  2020-05-05       Impact factor: 5.834
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.